1.      Abell, A., E. Ernst, and J.P. Bonde, Semen quality and sexual hormones in greenhouse workers. Scandinavian journal of work, environment & health, 2000: p. 492–500.

2.      Aho, B., Disrupting regulation: understanding industry engagement on endocrine-disrupting chemicals. Science and Public Policy, 2017. 44(5): p. 698–706.

3.      Alonso-Magdalena, P., et al., Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environmental health perspectives, 2010. 118(9): p. 1243.

4.      Axelstad, M., et al., EDC IMPACT: Reduced sperm counts in rats exposed to human relevant mixtures of endocrine disrupters. Endocrine connections, 2018. 7(1): p. 139–148.

5.      Bansal, R. and R.T. Zoeller, Polychlorinated biphenyls (Aroclor 1254) do not uniformly produce agonist actions on thyroid hormone responses in the developing rat brain. Endocrinology, 2008. 149(8): p. 4001–4008.

6.      Barker, D.J., The developmental origins of adult disease. European journal of epidemiology, 2003: p. 733–736.

7.      Bay, K., et al., Testicular dysgenesis syndrome: possible role of endocrine disrupters. Best Practice & Research Clinical Endocrinology & Metabolism, 2006. 20(1): p. 77–90.

8.      Biro, F.M., et al., Pubertal assessment method and baseline characteristics in a mixed longitudinal study of girls. Pediatrics, 2010. 126(3): p. e583–e590.

9.      Boas, M., U. Feldt-Rasmussen, and K.M. Main, Thyroid effects of endocrine disrupting chemicals. Molecular and cellular endocrinology, 2012. 355(2): p. 240–248.

10.  Bouskine, A., et al., Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein–coupled estrogen receptor. Environmental health perspectives, 2009. 117(7): p. 1053.

11.  Braun, J.M., et al., Exposures to environmental toxicants and attention deficit hyperactivity disorder in US children. Environmental health perspectives, 2006. 114(12): p. 1904.

12.  Braun, J.M., et al., Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics, 2011. 128(5): p. 873–882.

13.  Calafat, A.M. and L.L. Needham, Human exposures and body burdens of endocrine-disrupting chemicals, in Endocrine-disrupting chemicals: from basic research to clinical practice. 2007, Springer. p. 253–268.

14.  Calafat, A.M., et al., Exposure of the US population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environmental health perspectives, 2007. 116(1): p. 39.

15.  Calhoun, K.C., et al., Bisphenol A exposure alters developmental gene expression in the fetal rhesus macaque uterus. PloS one, 2014. 9(1): p. e85894.

16.  Cano-Sancho, G., A.G. Salmon, and M.A. La Merrill, Association between exposure to p, p′-DDT and its metabolite p, p′-DDE with obesity: integrated systematic review and meta-analysis. Environmental health perspectives, 2017. 125(9): p. 096002.

17.  Colón, I., et al., Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environmental health perspectives, 2000. 108(9): p. 895.

18.  Dees, C., et al., Estrogenic and DNA-damaging activity of Red No. 3 in human breast cancer cells. Environmental Health Perspectives, 1997. 105(Suppl 3): p. 625.

19.  Diamanti-Kandarakis, E., et al., Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocrine reviews, 2009. 30(4): p. 293–342.

20.  Dickerson, S.M., et al., Endocrine disruption of brain sexual differentiation by developmental PCB exposure. Endocrinology, 2011. 152(2): p. 581–594.

21.  Dohán, O., et al., The Na+/I− symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proceedings of the National Academy of Sciences, 2007. 104(51): p. 20250–20255.

22.  Gore, A.C., et al., EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals. Endocrine reviews, 2015. 36(6): p. E1–E150.

23.  Gore, A.C., et al., Endocrine Disrupting Chemicals: Threats to Human Health. The Endocrine Society and IPEN. February, 2024.

24.  Gray Jr, L., et al., Effects of environmental antiandrogens on reproductive development in experimental animals. Apmis, 2001. 109(S103): p. S302–S319.

25.  Hauser, R. and A. Calafat, Phthalates and human health. Occupational and environmental medicine, 2005. 62(11): p. 806–818.

26.  Herbst, A.L., et al., Prenatal exposure to stilbestrol: a prospective comparison of exposed female offspring with unexposed controls. New England Journal of Medicine, 1975. 292(7): p. 334–339.

27.  Heudorf, U., V. Mersch-Sundermann, and J. Angerer, Phthalates: toxicology and exposure. International journal of hygiene and environmental health, 2007. 210(5): p. 623–634.

28.  Horton, M.K., et al., CO-occurring exposure to perchlorate, nitrate and thiocyanate alters thyroid function in healthy pregnant women. Environmental research, 2015. 143: p. 1–9.

29.  Hunt, P.A., et al., The bisphenol A experience: a primer for the analysis of environmental effects on mammalian reproduction. Biology of reproduction, 2009. 81(5): p. 807–813.

30.  Jin, Y., L. Wang, and Z. Fu, Oral exposure to atrazine modulates hormone synthesis and the transcription of steroidogenic genes in male peripubertal mice. General and comparative endocrinology, 2013. 184: p. 120–127.

31.  Kelce, W.R., et al., Persistent DDT metabolite p, p'–DDE is a potent androgen receptor antagonist. Nature, 1995. 375(6532): p. 581–585.

32.  La Merrill, M.A., et al., Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nature Reviews Endocrinology, 2020. 16(1): p. 45–57.

33.  Legler, J., Comparison of in vivo and in vitro reporter gene assays for short-term screening of estrogenic activity. Environ. Sci. Technol., 2000. 34: p. 4439–4444.

34.  Mendiola, J., et al., Are environmental levels of bisphenol a associated with reproductive function in fertile men? Environmental health perspectives, 2010. 118(9): p. 1286.

35.  Mouritsen, A., et al., Hypothesis: exposure to endocrine‐disrupting chemicals may interfere with timing of puberty. International journal of andrology, 2010. 33(2): p. 346–359.

36.  Mylchreest, E., et al., Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di (n-butyl) phthalate. Reproductive toxicology, 2002. 16(1): p. 19–28.

37.  Ne, S., Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod, 2001. 16: p. 972–978.

38.  Ostby, J., et al., Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicology and industrial health, 1999. 15(1-2): p. 48–64.

39.  Parks, L.G., et al., The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicological sciences, 2000. 58(2): p. 339–349.

40.  Rajapakse, N., E. Silva, and A. Kortenkamp, Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environmental health perspectives, 2002. 110(9): p. 917.

41.  Satya, S., et al., Guidance document on standardised test guidelines for evaluating chemicals for endocrine disruption. 2012.

42.  Sharpe, R.M., Pathways of endocrine disruption during male sexual differentiation and masculinisation. Best practice & research Clinical endocrinology & metabolism, 2006. 20(1): p. 91–110.

43.  Singh, S. and S.S.-L. Li, Epigenetic effects of environmental chemicals bisphenol A and phthalates. International journal of molecular sciences, 2012. 13(8): p. 10143–10153.

44.  Souter, I., et al., The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments. Reproductive toxicology, 2013. 42: p. 224–231.

45.  Swan, S.H., et al., Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental health perspectives, 2005. 113(8): p. 1056.

46.  Vandenberg, L.N., et al., Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocrine reviews, 2012. 33(3): p. 378–455.

47.  Vandenberg, L.N., P.A. Hunt, and A.C. Gore, Endocrine disruptors and the future of toxicology testing—lessons from CLARITY–BPA. Nature reviews endocrinology, 2019. 15(6): p. 366–374.

48.  Walker, C.L., Minireview: epigenomic plasticity and vulnerability to EDC exposures. Molecular Endocrinology, 2016. 30(8): p. 848–855.

49.  Walker, D.M. and A.C. Gore, Epigenetic impacts of endocrine disruptors in the brain. Frontiers in Neuroendocrinology, 2017. 44: p. 1–26.

50.  Xie, G., et al., Association between phthalate exposure and reproductive health in patients undergoing assisted reproductive treatment: A systematic review and meta-analysis. Reproductive Toxicology, 2025. 136: p. 108948.

51.  Zama, A.M. and M. Uzumcu, Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes. Endocrinology, 2009. 150(10): p. 4681–4691.

52.  Zoeller, R. and J. Rovet, Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. Journal of neuroendocrinology, 2004. 16(10): p. 809–818.

53.  Zoeller, R.T., et al., Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society. Endocrinology, 2012. 153(9): p. 4097–4110.